Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Elektronisk overvågningsanordning for patientrapporterede resultater og funktion til forbedring af patientcentreret pleje hos patienter med mave-tarmkræft, der gennemgår operation

11. november 2026 opdateret af: City of Hope Medical Center

Elektronisk overvågning af patientrapporterede resultater og funktion i GI-kræftkirurgi: En gennemførlighedsundersøgelse

This pilot clinical trial studies an electronic monitoring device of patient-reported outcomes (PROs) and function in improving patient-centered care in patients with gastrointestinal cancer undergoing surgery. Electronic monitoring is a technology-based way of asking patients about the quality of life, symptoms, and activity using online surveys and an activity tracking watch may make it easier for patients to tell their doctors and nurses about any issues before and after surgery. Electronic systems of assessing PROs may increase the depth and accuracy of available clinical data, save administrative time, prompt early intervention that improves the patient experience, foster patient-provider communication, improve patient safety, and enhance the consistency of data collection across multiple sites.

Studieoversigt

Detaljeret beskrivelse

PRIMARY OBJECTIVES:

I. To determine the feasibility of administration of electronic patient-reported outcomes and functional assessment in gastrointestinal (GI) cancer surgery (gastric, colorectal, liver, pancreas).

II. Determine percentage of patients able to complete > 80% of MD. Anderson Symptom Inventory (MDASI) and European Quality of LIfe-5 Dimensions (EQ-5D) web-based surveys.

III. Determine percentage of patients able to wear the wristband device at least 1 week post-operatively.

IV. Determine length of time to complete the web-based surveys.

V. Determine length of time patients are able to wear the wristband device, before and after surgery.

SECONDARY OBJECTIVES:

I. Determine the percentage of patients who did not enroll in the study and analyze the reasons why. This will be accomplished using: 1) the number of patients asked to participate; 2) the number of patients who declined to participate, and 3) reasons for declining participation.

II. Responses from the Satisfaction Tool will be used to assess: 1) ease of use of web-based surveys and wristband device; 2) feedback on items in the web-based surveys that are distressing or difficult to comprehend; 3) feedback on length of surveys and timing of administration; and 4) suggestions for items that were not covered but should be added.

III. Calculate the mean number of missing items within each questionnaire to identify individual or subsets of questions that are difficult to answer.

OUTLINE:

Patients complete online surveys comprising questions about quality of life, symptoms, and activity level, and wear a wristband device (Vivofit watch) 3-7 days prior to and after surgery. After going home, patients complete the symptom survey three times a week and quality of life survey once a week for 2 weeks post-surgery.

After completion of study, patients are followed up for 1 month.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

22

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • California
      • Duarte, California, Forenede Stater, 91010
        • City of Hope Medical Center

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

21 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Scheduled to undergo surgery for primary or secondary gastric, colorectal, liver, or pancreas cancer
  • Able to read and understand English
  • Patients across all stages of disease
  • There are no restrictions related to performance status or life expectancy
  • This protocol is eligible for waiver of informed consent documentation; all subjects must have the ability to understand and the willingness to provide verbal informed consent

Exclusion Criteria:

  • Research participants who have no computer and internet access and/or do not use a computer even if one is present in the household
  • Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Enhedens gennemførlighed
  • Tildeling: N/A
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Supportive Care (Vivofit watch, online surveys)

Patients complete online surveys comprising questions about quality of life, symptoms, and activity level, and wear a wristband device (Vivofit watch) 3-7 days prior to and after surgery. After going home, patients complete the symptom survey three times a week and quality of life survey once a week for 2 weeks post-surgery.

Ancillary studies

Andre navne:
  • Livskvalitetsvurdering

Ancillary studies

Complete online surveys

Wear Vivofit watch

Andre navne:
  • Overvåge

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Mean time patients are able to tolerate wearing the wristband device, both before and after surgery
Tidsramme: Up to 1 month

Descriptive statistics will be used to describe the distribution of time (before and after surgery) a patient is able to wear the wristband device.

Up to 1 month
Mean time to complete the web based questionnaires MDASI and EQ-5D, as well as the Self Geriatric Assessment Measure
Tidsramme: Up to 1 month

Descriptive statistics will be used to describe the distribution of time to complete each assessment.

Up to 1 month
Median time patients are able to tolerate wearing the wristband device, both before and after surgery
Tidsramme: Up to 1 month

Descriptive statistics will be used to describe the distribution of time (before and after surgery) a patient is able to wear the wristband device.

Up to 1 month
Median time to complete the web based questionnaires MDASI and EQ-5D, as well as the Self Geriatric Assessment Measure
Tidsramme: Up to 1 month

Descriptive statistics will be used to describe the distribution of time to complete each assessment.

Up to 1 month
Percentage of patients who are able to complete the web-based questionnaires MDASI and EQ-5D
Tidsramme: Up to 1 month

Descriptive statistics will be reported. Patients who complete at least 80% of all scheduled MDASI and EQ-5D questionnaires will be indicated as able to complete the web-based questionnaires. The true population proportion will be estimated with 95% confidence interval of half-width no more than 0.16.

Up to 1 month
Percentage of patients who are able to wear the wristband device for at least 1 week post-operatively
Tidsramme: Up to 1 week post-operatively

Estimated with 95% confidence interval of half-width no more than 16%.

Up to 1 week post-operatively

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Brugervenlighed for webbaserede undersøgelser og armbåndsenhed, målt ved svar fra Satisfaction Tool
Tidsramme: Op til 1 måned
Op til 1 måned
Feedback på emner i de webbaserede undersøgelser, der er foruroligende eller svære at forstå, målt ved svar fra Satisfaction Tool
Tidsramme: Op til 1 måned
Op til 1 måned
Feedback på længden af ​​undersøgelser og timing af administration, målt ved svar fra Satisfaction Tool
Tidsramme: Op til 1 måned
Op til 1 måned
Forslag til emner, der ikke var dækket, men som bør tilføjes, målt ved svar fra Satisfaction Tool
Tidsramme: Op til 1 måned
Op til 1 måned
Mean number of missing items within each questionnaire
Tidsramme: Up to 1 month

Mean number of missing items within each questionnaire will be calculated to identify individual or subsets of questions that are difficult to answer.

Up to 1 month
Percentage of patients who did not enroll in the study-composite outcome of multiple measure listed
Tidsramme: Up to 1 month

Percentage of patients who did not enroll in the study will be determined and the reasons why will be analyzed. This will be accomplished using: i) the number of patients asked to participate, ii) the number of patients who declined to participate, and iii) reasons for declining participation.

Up to 1 month

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Samarbejdspartnere

Efterforskere

  • Ledende efterforsker: Virginia Sun, City of Hope Medical Center

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

22. juli 2015

Primær færdiggørelse (Faktiske)

31. juli 2016

Studieafslutning (Faktiske)

31. juli 2016

Datoer for studieregistrering

Først indsendt

26. juni 2015

Først indsendt, der opfyldte QC-kriterier

28. juli 2015

Først opslået (Anslået)

30. juli 2015

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

16. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

11. november 2026

Sidst verificeret

1. november 2026

Mere information

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner